ELI LILLY AND COMPANY Defined Benefit Plan, Expected Return (Loss) on Plan Assets
ELI LILLY AND COMPANY (LLY) reported Defined Benefit Plan, Expected Return (Loss) on Plan Assets of -$158.80 million for the 3-month period ending 2010-09-30, per its 10-Q filed 2010-10-29.
Discontinued › Notes › Compensation Related Costs › Defined Benefit Plan
us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets · last filed 2010-10-29
- ELI LILLY AND COMPANY defined benefit plan, expected return (loss) on plan assets for the quarter ending 2010-09-30 was -$158.80M.
- ELI LILLY AND COMPANY defined benefit plan, expected return (loss) on plan assets for the quarter ending 2009-09-30 was -$149.90M.
| Period end | Defined Benefit Plan, Expected Return (Loss) on Plan Assets 3 month | Defined Benefit Plan, Expected Return (Loss) on Plan Assets 9 month |
|---|---|---|
| 2010-09-30 | -$158.80M 10-Q · filed 2010-10-29 | -$476.40M 10-Q · filed 2010-10-29 |
| 2009-09-30 | -$149.90M 10-Q · filed 2010-10-29 | -$435.30M 10-Q · filed 2010-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |